BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Powell EE, Jonsson JR, Clouston AD. Dangerous liaisons: the metabolic syndrome and nonalcoholic fatty liver disease. Ann Intern Med. 2005;143:753-754. [PMID: 16287799 DOI: 10.7326/0003-4819-143-10-200511150-00015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Moriya T, Kitamori K, Naito H, Yanagiba Y, Ito Y, Yamagishi N, Tamada H, Jia X, Tsuchikura S, Ikeda K, Yamori Y, Nakajima T. Simultaneous changes in high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis and those underlying molecular mechanisms in novel SHRSP5/Dmcr rat. Environ Health Prev Med 2012;17:444-56. [PMID: 22407906 DOI: 10.1007/s12199-012-0273-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
2 Maleki I, Aminafshari MR, Taghvaei T, Hosseini V, Rafiei A, Torabizadeh Z, Barzin M, Orang E. Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(35): 12566-12573 [PMID: 25253959 DOI: 10.3748/wjg.v20.i35.12566] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
3 Hsu CL, Yen GC. Phenolic compounds: evidence for inhibitory effects against obesity and their underlying molecular signaling mechanisms. Mol Nutr Food Res 2008;52:53-61. [PMID: 18081207 DOI: 10.1002/mnfr.200700393] [Cited by in Crossref: 120] [Cited by in F6Publishing: 109] [Article Influence: 8.6] [Reference Citation Analysis]
4 Riley P, O'Donohue J, Crook M. A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease. J Clin Pathol 2007;60:1384-91. [PMID: 17483247 DOI: 10.1136/jcp.2006.044891] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
5 Fierbinteanu Braticevici C, Sporea I, Panaitescu E, Tribus L. Value of Acoustic Radiation Force Impulse Imaging Elastography for Non-invasive Evaluation of Patients with Nonalcoholic Fatty Liver Disease. Ultrasound in Medicine & Biology 2013;39:1942-50. [DOI: 10.1016/j.ultrasmedbio.2013.04.019] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
6 Fierbinteanu-Braticevici C, Dina I, Petrisor A, Tribus L, Negreanu L, Carstoiu C. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol. 2010;16:4784-4791. [PMID: 20939106 DOI: 10.3748/wjg.v16i38.4784] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Fierbinteanu-Braticevici C, Dina I, Petrisor A, Tribus L, Negreanu L, Carstoiu C. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol 2010; 16(38): 4784-4791 [PMID: 20939106 DOI: 10.3748/wjg.v16.i38.4784] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
8 Touzin NT, Bush KN, Williams CD, Harrison SA. Prevalence of colonic adenomas in patients with nonalcoholic fatty liver disease. Therap Adv Gastroenterol. 2011;4:169-176. [PMID: 21694801 DOI: 10.1177/1756283x11402118] [Cited by in Crossref: 33] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
9 Pi Z, Wang M, Lin H, Guo Y, Chen S, Diao X, Xia H, Liu G, Zeng J, Zhang X, Chen X. Viscoelasticity measured by shear wave elastography in a rat model of nonalcoholic fatty liver disease: comparison with dynamic mechanical analysis. Biomed Eng Online 2021;20:45. [PMID: 33941179 DOI: 10.1186/s12938-021-00879-3] [Reference Citation Analysis]
10 Bray TJ, Chouhan MD, Punwani S, Bainbridge A, Hall-Craggs MA. Fat fraction mapping using magnetic resonance imaging: insight into pathophysiology. Br J Radiol 2018;91:20170344. [PMID: 28936896 DOI: 10.1259/bjr.20170344] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
11 Farrell GC. The liver and the waistline: Fifty years of growth. J Gastroenterol Hepatol. 2009;24 Suppl 3:S105-S118. [PMID: 19799688 DOI: 10.1111/j.1440-1746.2009.06080.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
12 Riley P, Sudarshi D, Johal M, Benedict A, Panteli J, Crook M, O’donohue J. Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective study: Weight loss, diet and statins in NAFLD. International Journal of Clinical Practice 2008;62:374-81. [DOI: 10.1111/j.1742-1241.2007.01666.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
13 Machado UF, Schaan BD, Seraphim PM. Transportadores de glicose na síndrome metabólica. Arq Bras Endocrinol Metab 2006;50:177-89. [DOI: 10.1590/s0004-27302006000200004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
14 Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology. 2007;132:2087-2102. [PMID: 17498505 DOI: 10.1053/j.gastro.2007.03.052] [Cited by in Crossref: 952] [Cited by in F6Publishing: 844] [Article Influence: 63.5] [Reference Citation Analysis]
15 Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, Cavallo MG. Strong association between nonalcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011;9:85. [PMID: 21749681 DOI: 10.1186/1741-7015-9-85] [Cited by in Crossref: 187] [Cited by in F6Publishing: 169] [Article Influence: 17.0] [Reference Citation Analysis]
16 Ducluzeau PH, Manchec-Poilblanc P, Roullier V, Cesbron E, Lebigot J, Bertrais S, Aubé C. Distribution of abdominal adipose tissue as a predictor of hepatic steatosis assessed by MRI. Clin Radiol 2010;65:695-700. [PMID: 20696296 DOI: 10.1016/j.crad.2010.03.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
17 Sevastianos VA, Hadziyannis SJ. Nonalcoholic fatty liver disease: from clinical recognition to treatment. Expert Rev Gastroenterol Hepatol. 2008;2:59-79. [PMID: 19072371 DOI: 10.1586/17474124.2.1.59] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
18 Czaja MJ. JNK regulation of hepatic manifestations of the metabolic syndrome. Trends Endocrinol Metab 2010;21:707-13. [PMID: 20888782 DOI: 10.1016/j.tem.2010.08.010] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 6.3] [Reference Citation Analysis]
19 Zhang X, Gao X, Zhang P, Guo Y, Lin H, Diao X, Liu Y, Dong C, Hu Y, Chen S, Chen X. Dynamic mechanical analysis to assess viscoelasticity of liver tissue in a rat model of nonalcoholic fatty liver disease. Med Eng Phys 2017;44:79-86. [PMID: 28284571 DOI: 10.1016/j.medengphy.2017.02.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]